New insider activity at Revvity ( (RVTY) ) has taken place on February 8, 2025.
Director Michelle McMurry-Heath has recently sold 1,970 shares of Revvity stock, amounting to a significant transaction worth $235,395.
Recent Updates on RVTY stock
Recent developments for Revvity’s stock have been influenced by positive fourth-quarter results and optimistic future projections. Baird raised its price target citing strong Q4 results and a solid outlook for 2025. KeyBanc also increased its price target, attributing the change to positive company guidance for FY25, despite a temporary margin reduction in Q1 due to strategic investments in reagents, a promising growth area. Barclays raised its price target, noting that the life science tools group’s conservative Q1 guidance makes it less likely for the company to miss targets. Revvity reported a Q4 adjusted EPS that beat consensus estimates, driven by growth in the Life Sciences reagents, software, and diagnostics segments, despite challenges in the instrumentation business and FX headwinds. The company’s strategic partnerships and innovations, along with a strong financial position, contribute to a positive outlook for upcoming fiscal years.
More about Revvity
YTD Price Performance: 6.83%
Average Trading Volume: 897,352
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $14.5B
Questions or Comments about the article? Write to editor@tipranks.com